Crossing the 30s is not just about celebrating a milestone; it’s a phase when the body silently starts showing the early signs of wear and tear. Energy may not feel the same, metabolism begins to slow ...

Genetic disease drug developer PYC Therapeutics (ASX:PYC) reported September quarter outflows of $17.4 million, but still had end-of-quarter cash of $123 million. PYC has a busy slate of three ...

LONDON, Sept 22 (Reuters) - Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both ...

New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say. By Maureen Farrell For individuals suffering ...

CAMBRIDGE, Mass., June 15, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

Hemoptysis can signal conditions ranging from the mild to life-threatening. Here’s how to determine which cases demand immediate intervention. Hemoptysis is frequently encountered by primary-care ...